ARTICLE | Company News
Cobra Bio, Pharmexa deal
February 5, 2007 8:00 AM UTC
CBF will manufacture PHARMX’s Px10 7 therapeutic vaccine for Phase I trials to treat bone disorders, such as osteoporosis, rheumatoid arthritis (RA) and bone metastasis. The protein vaccine against re...